BCG Live (Sanofi)

N/A

Report date: 2023/10/26 20:01:00

Base Information

Drug NameBCG Live (Sanofi)
Drug Alias Name卡介苗 - 赛诺菲BCG Live (Intravesical)TheraCysImmucystPMCJ-9
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsUrinary Bladder Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/05/21
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesSanofi Pasteur
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL03AX03
Related LinksN/A